These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2719371)
21. Methods of implantable cardioverter-defibrillator-pacemaker insertion to avoid interactions. Spotnitz HM; Ott GY; Bigger JT; Steinberg JS; Livelli F Ann Thorac Surg; 1992 Feb; 53(2):253-7. PubMed ID: 1731664 [TBL] [Abstract][Full Text] [Related]
22. Potential role of antitachycardia pacing alerts for the reduction of emergency presentations following shocks in patients with implantable cardioverter-defibrillators: implications for the implementation of remote monitoring. Boulé S; Ninni S; Finat L; Botcherby EJ; Kouakam C; Klug D; Marquié C; Brigadeau F; Lacroix D; Kacet S; Guédon-Moreau L Europace; 2016 Dec; 18(12):1809-1817. PubMed ID: 26711741 [TBL] [Abstract][Full Text] [Related]
23. The automatic internal cardioverter defibrillator (AICD): description and guidelines for interaction during cardiac arrest. White RD; Feldman RA Ann Emerg Med; 1989 May; 18(5):586-8. PubMed ID: 2719372 [TBL] [Abstract][Full Text] [Related]
24. Long-term experience with the automatic implantable cardioverter-defibrillator in a patient with ventricular tachyarrhythmias. Bytesník J; Náprstek Z; Fabián J Czech Med; 1988; 11(2):114-8. PubMed ID: 3137004 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of ventricular tachyarrhythmias with an implantable cardioverter-defibrillator system]. Frohner K; Kaltenbrunner W; Laufer G; Laczkovics A; Wolner E; Steinbach K Wien Klin Wochenschr; 1988 Mar; 100(6):167-73. PubMed ID: 3376474 [TBL] [Abstract][Full Text] [Related]
26. Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias. Kay GN; Plumb VJ; Dailey SM; Epstein AE Am J Med; 1990 Jan; 88(1N):25N-34N. PubMed ID: 2195882 [TBL] [Abstract][Full Text] [Related]
27. The wearable cardioverter-defibrillator: current technology and evolving indications. Reek S; Burri H; Roberts PR; Perings C; Epstein AE; Klein HU; ; Lip G; Gorenek B; Sticherling C; Fauchier L; Goette A; Jung W; Vos MA; Brignole M; Elsner C; Dan GA; Marin F; Boriani G; Lane D; Blomström-Lundqvist C; Savelieva I Europace; 2017 Mar; 19(3):335-345. PubMed ID: 27702851 [TBL] [Abstract][Full Text] [Related]
28. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077 [TBL] [Abstract][Full Text] [Related]
29. Right Ventricular Pacing Increases Risk of Appropriate Implantable Cardioverter-Defibrillator Shocks Asymmetrically: An Analysis of the ALTITUDE Database. Cronin EM; Jones P; Seth MC; Varma N Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29030379 [TBL] [Abstract][Full Text] [Related]
30. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device. Francisco GM; Sharma S; Dougherty AH; Kantharia BK Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529 [TBL] [Abstract][Full Text] [Related]
32. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. Fogoros RN; Fiedler SB; Elson JJ Ann Intern Med; 1987 Nov; 107(5):635-41. PubMed ID: 3662277 [TBL] [Abstract][Full Text] [Related]
33. [Implantable automatic defibrillator. Evaluation after 8 years of use]. Rapoport P; Leenhardt A; Leclercq JF; Coumel P; Slama R Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1509-15. PubMed ID: 1763917 [TBL] [Abstract][Full Text] [Related]
34. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator. Myerburg RJ; Luceri RM; Thurer R; Cooper DK; Zaman L; Interian A; Fernandez P; Cox M; Glicksman F; Castellanos A J Am Coll Cardiol; 1989 Aug; 14(2):508-14. PubMed ID: 2754136 [TBL] [Abstract][Full Text] [Related]
35. Silicone pouch for protection of automatic implantable cardioverter-defibrillator leads. Cilley JH; Cernaianu AC; Libby JA; Baldino WA; DelRossi AJ Ann Thorac Surg; 1991 Mar; 51(3):504-5. PubMed ID: 1998440 [TBL] [Abstract][Full Text] [Related]
36. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies. Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327 [TBL] [Abstract][Full Text] [Related]
37. Continuing experience with the automatic implantable cardioverter defibrillator. Paull DL; Fellows CL; Guyton SW; Anderson RP Am J Surg; 1992 May; 163(5):502-4. PubMed ID: 1575307 [TBL] [Abstract][Full Text] [Related]
38. Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report. Cagli KE; Guray U; Akpinar I; Sen N; Aras D; Topaloglu S J Electrocardiol; 2010; 43(1):68-70. PubMed ID: 19446839 [TBL] [Abstract][Full Text] [Related]